Jeffrey B. Mirviss, EVP&Pres, Periph Intervent at BOSTON SCIENTIFIC CORP (BSX), sold 13,680 shares at $43.54 ($596K) on 2022-01-04, disclosed to the SEC on 2022-01-05.
Seasonal sale ($596k) by EVP&Pres, Periph Intervent — this insider has traded BSX in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.54 | 6,840 | $298K | 50.0% |
| 2 | $43.54 | 6,840 | $298K | 50.0% |
| Total | $43.54 avg | 13,680 | $596K | 100% |
| Filing → |
| BSX | SELL | 2025-02-13 | $2.7M | — | Filing → |
| BSX | SELL | 2025-01-03 | $1.3M | — | Filing → |
| BSX | SELL | 2024-05-30 | $9.6M | — | Filing → |